HTFL Stock: Price, Earnings History and SEC Filings
Heartflow, Inc. (HTFL) last traded at $59.05, down 2.45% on the latest session and up 18.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.16 against an analyst estimate of $-0.22, a beat of 27.3%.
$59.05 -2.45%
1 month+18.69%
52-week high$60.56
52-week low$20.13
Volume2.25M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
HTFL earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 13, 2026 | $-0.16 | $-0.22 | +27.27% |
| Mar 2026 | May 14, 2026 | $-0.23 | $-0.24 | +4.17% |
| Dec 2025 | Mar 18, 2026 | $-0.18 | $-0.24 | +25.00% |
| Sep 2025 | Nov 12, 2025 | $-0.35 | $-0.27 | -29.63% |
HTFL beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for HTFL
SEC filing data is not available right now. You can search for HTFL on SEC EDGAR.
HTFL news
- TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of PatientsNov 1, 2026 · finance.yahoo.com
- Boston Scientific (BSX) Wins FDA Clearances, Starts Elite AF Trial And Expands AI PushOct 29, 2026 · finance.yahoo.com
- Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue EstimatesOct 27, 2026 · finance.yahoo.com
- 3 AI Stocks To Own In October 2026Oct 25, 2026 · finance.yahoo.com
- Pfizer And 2 Other AI Healthcare Stocks To WatchOct 24, 2026 · finance.yahoo.com
- Elucid Statement on Heartflow Lawsuit: Reaffirms Mission, Confidence in Its Technology, and Commitment to Patients and PhysiciansOct 23, 2026 · finance.yahoo.com
- Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026Oct 19, 2026 · finance.yahoo.com
About Heartflow, Inc.
Heartflow, Inc. (HTFL) is a US-listed public company on Nasdaq.